Skip to content

Nuvation Bio NUVB CN — Revenue

Similar metrics at other companies

Cabot Corporation logo
CBTCN — Revenue
$232.75M-5.3%
Fortune Brands Innovations logo
FBINCN — Revenue
$36.8M-37.0%
Universal Display logo
OLEDCN — Revenue
$43.64M-38.6%
Weyerhaeuser logo
WYCN — Revenue
$2.75M-88.0%
Payoneer Global Inc. logo
PAYOCN — Revenue
$86.62M+2.0%
Ceco Environmental logo
CECOCN — Revenue
$14.56M-1.6%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's cn — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's CN — revenue?
Nuvation Bio (NUVB) reported CN — revenue of $5.19M in Q1 2026.
How has Nuvation Bio's CN — revenue changed year-over-year?
Nuvation Bio's CN — revenue increased by 78.8% year-over-year, from $2.9M to $5.19M.
What does CN — revenue mean?
This metric represents the total gross income generated by the company's operations within the specified geographic segment. It reflects the market demand and commercial success of the company's therapeutic offerings in this region. Monitoring this figure helps investors assess the company's regional growth trajectory and market penetration.